Plain-English translation of NCT07070518 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help people with advanced solid tumors — cancers that have either come back or stopped responding to standard treatments. The study will carefully measure how safe the medication is and whether it helps shrink or slow down the cancer. Researchers will work with about 350 participants across multiple hospitals.
Many people with advanced cancers run out of treatment options when standard therapies stop working. This trial exists to find out whether this new medication could offer hope to patients who have limited choices left.
You likely qualify if…
You likely don't qualify if…
The study happens in two parts. First, a small group will receive increasing doses of the medication to find the safest dose — this is the safety phase. Then, a larger group will receive the established dose and have their tumors carefully monitored to see if the medication works. You'll have regular visits to the hospital or clinic for blood tests, scans, and check-ins with your doctor. Some participants will need to provide tissue biopsies before starting and during treatment to help researchers understand how the medication is working.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China